Ledger.Open graph →
SEC Form D · filed October 23, 2014

New Haven Pharmaceuticals, Inc

Offering
$21.8M
Sold
$11.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

William Sessa · New Haven, CTDirectorLarry Dillaha · New Haven, CTDirectorHarry Penner, Jr · New Haven, CTExec · DirectorPatrick Fourteau · New Haven, CTExec · DirectorDaniel Wagner · New Haven, CTDirectorNancy Motola · New Haven, CTExecCarl Dilley · Clearwater, FLExec · DirectorAlan Tooker · George Town, Cayman IslandsExec · DirectorDamian Juric · George Town, Cayman IslandsDirectorGuy Zajonc · Clearwater, FLDirectorSteven Amour · Clearwater, FLExec · DirectorMicah Eldred · Clearwater, FLExec · DirectorChristine Zitman · Clearwater, FLDirectorDavid Littleton · Grand Cayman, Cayman IslandsExecLarry Dillaha · Tucker, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗